The government owned Shanghai Pharma is giving out more than $550 million to buy the China operations of U.S.-based Card...
A consortium of leading Chinese pharmaceutical manufacturers, distributors, venture capital partners and e-commerce comp...
A drugmaker controlled by Chinese conglomerate Fosun International, Shanghai Fosun Pharmaceutical (Group) has agreed to ...
Shanghai-based biotech startup EOC Pharma has raised $32 million from Chinese investors to help it bring a series of can...
A group of researchers at multiple institutions in China have collaborated to develop the Smart System of Disease Manage...
Teva Pharmaceutical Industries Ltd is planning to set up a joint venture with Guangzhou Pharmaceutical Holdings Ltd to m...
Eisai Co., Ltd. announced that the China Food and Drug Administration (CFDA) has accepted for review a New Drug Ap...
China’s Fosun Pharma recently announced the acquisition of French drug distributor, Tridem for up to 63 million eu...
Creating a new chapter in the history of China and Indian pharmaceutical industry, China’s drug giant Fosun Pharma...
The military-backed Bioengineering Institute of the Chinese Academy of Military Medical Sciences and private drugmaker C...
A group of scientists from the Chinese Academy of Sciences have developed a magical suit fitted with large-area textile ...
In line with its expansion strategies, Shanghai based biotechnology and medical-device developer WuXi AppTec Group has a...
In a filing with Shanghai stock exchange, Shanghai pharma said that it has Pharma submitted two non-binding bids to buy ...
The fully integrated plasma based biopharmaceutical company China Biologic has agreed to acquire 80 per cent equity inte...
Beijing recently announced new rules that will speed up approvals of medicines and medical devices, easing bottlenecks i...
Weeks after Chinese pharmaceutical giant Fosun tweaked its acquisition of Hyderabad-based Gland Pharma for $1 billion (R...
A group of Chinese researchers have reported that a Chinese traditional ink could noninvasively and effectively treat ca...
Chinese pharmaceutical firm, Simcere, has inked an exclusive agreement with Amgen to co-develop and commercialize four b...
